These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4119105)

  • 1. Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.
    Currie GA; Basham C
    Br J Cancer; 1972 Dec; 26(6):427-38. PubMed ID: 4119105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.
    Currie GA; Lejeune F; Fairley GH
    Br Med J; 1971 May; 2(5757):305-10. PubMed ID: 4930209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of active immunization with irradiated tumour cells on specific serum inhibitors of cell-mediated immunity in patients with disseminated cancer.
    Currie GA
    Br J Cancer; 1973 Jul; 28(1):25-35. PubMed ID: 4724610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The lymphocyte cytotoxicity test in tumor immunology (author's transl)].
    Pees HW
    Klin Wochenschr; 1975 Jan; 53(1):1-6. PubMed ID: 47411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans.
    Vose BM; Vanky F; Klein E
    Int J Cancer; 1977 Oct; 20(4):512-9. PubMed ID: 914394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
    Surg Forum; 1975; 26():122-4. PubMed ID: 56048
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma.
    Nind AP; Matthews N; Pihl EA; Rolland JM; Nairn RC
    Br J Cancer; 1975 Jun; 31(6):620-9. PubMed ID: 51647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of circulating antigen as an inhibitor of tumour immunity in man.
    Currie G
    Br J Cancer Suppl; 1973 Aug; 1():153-61. PubMed ID: 4804278
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of tumour associated antigens on human colonic carcinomata.
    Embleton MJ
    Br J Cancer Suppl; 1973 Aug; 1():142-52. PubMed ID: 4804277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte-mediated cytotoxicity on human tumor cells in vitro.
    Schwenke H; Schönfelder M
    Arch Geschwulstforsch; 1975; 45(8):802-9. PubMed ID: 1241765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular microcytotoxicity in human tumor systems: analysis of results.
    Oldham RK; Djeu JY; Cannon GB; Siwarski D; Herberman RB
    J Natl Cancer Inst; 1975 Dec; 55(6):1305-18. PubMed ID: 54436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human spontaneous lymphocyte-mediated cytotoxicity (SLMC) against malignant and normal tissue-derived target cell lines tested in autologous and allogeneic combinations by the microcytotoxicity assay.
    Vilien M; Troye-Blomberg M; Perlmann P; Wolf H; Rasmussen F
    Cancer Immunol Immunother; 1983; 14(3):137-44. PubMed ID: 6573229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificities in human cell-mediated cytotoxicity.
    Takasugi M; Akira D; Takasugi J; Mickey MR
    J Natl Cancer Inst; 1977 Jul; 59(1):69-75. PubMed ID: 69035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
    Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients.
    Ferrone S; Pellegrino MA
    J Natl Cancer Inst; 1977 May; 58(5):1201-4. PubMed ID: 67208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.